She received her PhD by the University of Barcelona in February 2021 under the supervision of Prof. Santiago Vázquez, developing urea-based compounds with a broad range of therapeutic applications. As part of her PhD, she did a five-month research placement within Prof. Knapp’s research group (Goethe-University, Frankfurt am Main), working on selective inhibitors as chemical probes. Her scientific background has been complemented with business knowledge, thanks to the participation in entrepreneurship programs and courses in intellectual property.

She has multidisciplinary expertise in various experimental topics, including organic and medicinal synthesis, electrophysiology (Patch Clamp Whole Cells) and IC50 determination in cell cultures. Currently, she is working as a R+D manager leading the optimization and scaling up of the synthesis processes of pharmaceutical active ingredients.

She has joined Dr. Carles Galdeano’s and Dr. Diego Muñoz-Torrero’s groups in collaboration with the Vall d’Hebron Institute of Oncology (VHIO). After obtaining her degree in Pharmacy at the Faculty of Pharmacy and Food Sciences at University of Barcelona in 2015, she started her PhD studies in Medicinal Chemistry under the supervision of Dr. Santiago Vázquez (2015 – 2020), working on a multidisciplinary project focused on the design, synthesis and evaluation of new soluble epoxide hydrolase (sEH) inhibitors with potential biological activity, and their applications in different inflammatory diseases. As a part of her PhD, she spent three months conducting research at the Institute of Cancer Research in London under the supervision of Dr. Swen Hoelder.

She is graduated in Chemistry and with a Master’s degree in Organic Chemistry from the University of Barcelona. In February 2022, she joined the group of Dr. Santiago Vázquez as a master’s student. Afterward, she did a two-month placement at the Center for Research in Biological Chemistry and Molecular Materials (CiQUS) at the University of Santiago de Compostela in Dr. Eddy Sotelo’s research group. In September 2022 she started her PhD under the supervision of Prof. Santiago Vázquez.

Javier Sánchez holds a Chemistry degree from the Autonomous University of Madrid and a master’s degree in Drug Discovery. He worked as a synthetic chemist at the Spanish National Cancer Research Center (CNIO), gaining experience in early-stage drug discovery. In September 2022, he began his Ph.D. under the supervision of Dr. Diego Muñoz-Torrero and Dr. Santiago Vázquez. His research focuses on designing, synthesizing, and evaluating new drugs with innovative mechanisms to treat neurodegenerative diseases and neuropathic pain.

Óscar studied Biology (BSc 1997) and Pharmacy (BSc 2002) at the University of Barcelona. Later on, he carried out a PhD in Synthetic Organic Chemistry under the supervision of Prof. J. Bosch, M. Amat and Dr. C. Escolano regarding total synthesis of natural products (UB, 2007). After a short postdoctoral stay in the group of Prof. J. Cossy (ESPCI, Paris, 2007) he worked in the group of Prof. V. Gouverneur (University of Oxford) for more than five years. After returning to Barcelona in 2013, he worked in different pharmaceutical and chemical companies. In July 2017, he joined BioPharma Synergies as a senior researcher, a position that he shared with a part-time Assistant Professor within our group until his untimely death in November 2021. We will always remember him as an outstanding chemist, an excellent mentor, and a wonderful friend.

She is graduated in Pharmacy from the University of Barcelona, specialized in industrial pharmacy and pharmaceutical research. In June 2021, she joined the group of Dr. Santiago Vázquez as an undergraduate student, where she gained practical experience in synthetic methods and basic laboratory techniques in organic chemistry. In September 2023, she began her Ph.D. under the supervision of Dr. Santiago Vázquez and Dra Andreea L. Turcu. Her research focuses on designing, synthesizing, and evaluating new drugs with innovative mechanisms to treat different types of chronic pain and neurodegenerative diseases.